MedTrace Logo

Role of Uterine Artery Embolization in Adenomyosis

NCT05597644 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-10-28

No results posted yet for this study

Summary

Management of symptomatizing women diagnosed with uterine adenomyosis, by uterine artery angioembolization as a minimally invasive replacement for hysterectomy. This is followed by assessment of the symptoms and MRI of the pelvis after 3 months.

Conditions

  • Adenomyosis

Interventions

PROCEDURE

Trans-arterial uterine artery embolization

transarterial angioembolization of uterine artery

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ehab Mansour, Assistant Professor · Assiut University

  • Abd ElKareem Hasan, Professor · Assiut University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-10-31
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05597644 on ClinicalTrials.gov